Tumor necrosis as a biomarker for response to neoadjuvant therapy in pancreatic cancer

Masatoshi Kudo; Masahiro Sugimoto; S. Kobayashi; M. Konishi; Naoto Gotohda

doi:10.1016/j.hpb.2024.03.287

Related publications

Article2020

The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Fatima Domenica Elisa De Palma, Gaetano Luglio, Francesca Paola Tropeano, G Pagano, Maria D’Armiento, Guido Guido Kroemer, Maria Chiara Maiuri, Giovanni Domenico De Palma

Article2021

Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions

Rita T. Lawlor, Paola Mattiolo, Andrea Mafficini, Seung‐Mo Hong, Maria Liliana Piredda, Sergio Vincenzo Taormina, Giuseppe Malleo, Giovanni Marchegiani, Antonio Pea, Roberto Salvia, Valentyna Kryklyva, Jae Il Shin, Lodewijk A.A. Brosens, Michèle Milella, Aldo Scarpa, Claudio Luchini

Article2012

Su1900 Tumor Infiltrating Macrophages as a Potential Predictive Biomarker of Response to 5-FU in Patients With Microsatellite-Stable Colorectal Cancer

Luigi Laghi, Paolo Bianchi, Fabio Grizzi, Giuseppe Di, Giuseppe Celesti, Massimo Roncalli, Alberto Mantovani, Alberto Malesci

Article2025

1617P Leucine-rich 2 glycoprotein 1 (LRG1) as potential systemic biomarker for response to neoadjuvant immune checkpoint blockade in stage III melanoma

Shizhen Chen, C.C.E. De Schrijver, H. Van Rossum, Theodora C. Linders, Lianne Hoeijmakers, M.W. Lucas, Esmée P. Hoefsmit, Irene L. M. Reijers, Petros Dimitriadis, B. van de Wiel, Karin E. de Visser, Astrid A.M. van der Veldt, Helena Eriksson, Geke A.P. Hospers, Richard A Scolyer, Karijn P.M. Suijkerbuijk, Ellen Kapiteijn, A.M. Menzies, G.V. Long, Christian U. Blank

Article2021

Cell death in pancreatic cancer: from pathogenesis to therapy

Rui Kang, Guido Guido Kroemer, Daolin Tang, Xin Chen, Herbert J. Zeh